Selection of dormant cells during treatment of T-lineage lymphoblastic leukemia and CREB as a therapeutic target

Haematologica. 2024 Jul 1;109(7):2316-2320. doi: 10.3324/haematol.2023.284335.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cyclic AMP Response Element-Binding Protein / genetics
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Humans
  • Molecular Targeted Therapy
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / genetics
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / metabolism
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / pathology

Substances

  • Cyclic AMP Response Element-Binding Protein

Grants and funding

Funding: The authors would like to gratefully acknowledge Children with Cancer UK, Newcastle Hospitals NHS Foundation Trust and JGW Paterson for funding this study.